F-star Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2017 to 2019

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
F-star Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2017 to 2019.
  • F-star Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 21.9M shares, a 6.01% increase year-over-year.
  • F-star Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 16.5M shares, a 12.6% increase from 2018.
  • F-star Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2018 was 14.6M shares, a 31.1% increase from 2017.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2019 16.5M +1.84M +12.6% Jan 1, 2019 Dec 31, 2019 10-K 2020-02-14
2018 14.6M +3.47M +31.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-14
2017 11.2M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.